Skip to main content

Time in Range

What's new

Rybelsus, a GLP-1 agonist pill already approved in Europe and the US, has just been approved by Health Canada for adults with type 2 diabetes Continue Reading »

Dr. Diana Isaacs on improving time in range, making the most of your data, and the barriers facing people with diabetes and their healthcare teams Continue Reading »

Rybelsus, a GLP-1 agonist pill already approved in the US, received positive feedback from the European Medicines Agency (EMA) in January and was just approved on Saturday Continue Reading »

Mark Harmel, MPH, CDCES, discusses how his clinic is moving to telemedicine in the time of COVID-19 and how to share data from many diabetes devices Continue Reading »

The Time in Range Coalition aims to help millions of people by promoting time in range in diabetes care Continue Reading »

Michael writes about how he used two main strategies – intermittent fasting and walking after meals ­– to put his type 2 diabetes into remission Continue Reading »

More time in range and lower stress! In this Trial Watch, Kerri Sparling shares her experience with Tandem's Control-IQ Continue Reading »

The diaTribe team was on the ground in Madrid, Spain to cover the latest news in diabetes technology from ATTD. Here are our top highlights from the conference! Continue Reading »

Pages